CINJ commences enrollment in three-drug combination trial for breast cancer

[News]

Researchers at The Cancer Institute of New Jersey (CINJ) are enrolling patients for a clinical trial, which aims to evaluate a new drug for breast cancer that has spread (metastatic) in combination with two chemotherapy agents called doxorubicin and cyclophosphamide.

More... (http://www.news-medical.net/news/20120618/CINJ-commences-enrollment-in-three-drug-combination-trial-for-breast-cancer.aspx)